MarketCap
Facebook
X
TelegramAphria Inc. DSO 2011-2026 | APHA
DSO Jährlich Aphria Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 55.2 | 133 | 178 | 104 | 107 | 732 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 732 | 55.2 | 218 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AbCellera Biologics
ABCL
|
173 | $ 3.64 | -1.89 % | $ 1.09 B |  Canada |
 |
ADMA Biologics
ADMA
|
74.6 | $ 16.45 | 0.43 % | $ 3.92 B |  USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
ANI Pharmaceuticals
ANIP
|
114 | $ 76.75 | 0.85 % | $ 1.48 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
115 | $ 19.93 | -1.14 % | $ 2.51 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
20.6 | $ 0.83 | 4.23 % | $ 4.53 M | China |
 |
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
47.5 | - | - | $ 521 M | USA |
 |
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | USA |
 |
Axsome Therapeutics
AXSM
|
105 | $ 163.82 | -0.14 % | $ 8.15 B | USA |
 |
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | USA |
 |
BridgeBio Pharma
BBIO
|
52.4 | $ 66.98 | 3.8 % | $ 12.8 B | USA |
 |
CymaBay Therapeutics
CBAY
|
182 | - | - | $ 3.45 B | USA |
 |
Avid Bioservices
CDMO
|
45.6 | - | - | $ 789 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
164 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
BioMarin Pharmaceutical
BMRN
|
88.9 | $ 60.75 | 3.79 % | $ 11.7 B | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
52.1 | - | - | $ 1.2 B | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
81.5 K | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M |  Germany |
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | Canada |
 |
Capricor Therapeutics
CAPR
|
31.9 | $ 25.71 | -0.5 % | $ 688 M | USA |
 |
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Codexis
CDXS
|
32.9 | $ 1.1 | 12.24 % | $ 80.7 M | USA |
 |
Certara
CERT
|
89.6 | $ 7.33 | 1.24 % | $ 1.18 B | USA |
 |
Evofem Biosciences
EVFM
|
68.8 | - | 7.55 % | $ 38.1 M | USA |